Corporate News Report
Fibrobiologics (FBLG) Trading Summary
Fibrobiologics (FBLG) experienced a 7.93 % increase during the 24‑hour period that ended at 07:49 AM Central Europe on Friday, 23 January 2026. The share price closed at approximately USD 1.02 on major exchanges. At the time of reporting, the market listed 7 million shares of Fibrobiologics. The company’s market capitalization is USD 6.9 million. In the preceding 24 hours, a total of USD 126.6 thousand worth of Fibrobiologics shares were traded.
Since the close of the previous month, Fibrobiologics has declined by 25.9 %. The 200‑day simple moving average is USD 2.58. The highest price recorded in the last 52 weeks was USD 9.60 on 03 March 2026, while the lowest price in the same period was USD 0.62 on 29 July 2026.
Comparative Performance of Related Stocks (Last 24 Hours)
| Company | Ticker | 24‑hour change | Current price | Market Capitalization |
|---|---|---|---|---|
| Trio Petroleum | TPET | –3.31 % | USD 1.52 | USD 7.8 million |
| Getty Images | GETY | –5.00 % | USD 0.02 | USD 8.1 million |
| Ciso Global | CISO | –0.57 % | USD 0.17 | USD 7.9 million |
| Aethlon Medical | AEMD | +2.37 % | USD 5.19 | USD 8.1 million |
| Bolt Biotherapeutics | BOLT | –3.94 % | USD 4.19 | USD 8.0 million |
Company Overview
FibroBiologics, Inc. is an early‑stage cell therapy company headquartered in Webster, United States. The firm focuses on developing FDA‑approved trials for fibroblast‑based treatments aimed at treating conditions such as degenerative disc disease, multiple sclerosis, cancer, wound healing, and other health disorders.